PMID- 11011218 OWN - NLM STAT- MEDLINE DCOM- 20001107 LR - 20051116 IS - 1262-3636 (Print) IS - 1262-3636 (Linking) VI - 26 IP - 4 DP - 2000 Sep TI - Post-prandial hyperglycemia. post-prandial hyperglycemia and diabetes. PG - 265-72 AB - Post-prandial hyperglycemia (PPHG) is an independent risk factor for the development of macrovascular complications. It is now recognized that normalizing post-prandial blood glucose is more difficult than normalizing fasting glucose. Many factors affect the post-prandial blood glucose excursion. The glycemic index of the meal depends on the nature of the ingested food and starch composition. Gastric emptying is influenced by various factors including gut hormones such as GIP and GLP1, which potentiate insulin secretion, especially in its acute first phase, now referred to as an incretin effect. They also modulate glucagon secretion. Post-prandial hyperglycemia is limited by uptake of glucose by the liver and by inhibition of endogenous glucose production in this organ. In healthy controls, hepatic glucose production is halved after a meal, whereas in glucose-intolerant individuals and type 2 diabetics this inhibition is impaired (20-30% versus 50%). The persistence of endogenous glucose production during the post-prandial phase appears to be the main culprit in the PPHG. This reduced decrease in endogenous glucose in glucose intolerant and type 2 diabetic patients depends not only on the first acute phase of insulin secretion, but above all on the non-suppressed glucagon level during the post-prandial phase. Glucagon levels fall in healthy control subjects during the post-prandial phase. Although peripheral glucose uptake by insulin-dependent tissues is altered in type 2 diabetic patients, it does not appear to be the major cause of the PPHG as there are patients with insulin resistance but without post-prandial hyperglycemia. FAU - Gin, H AU - Gin H AD - Service de Nutrition-Diabetologie, Hopital Haut Leveque Avenue de Magellan 33604 Pessac Cedex France. FAU - Rigalleau, V AU - Rigalleau V LA - eng PT - Journal Article PT - Review PL - France TA - Diabetes Metab JT - Diabetes & metabolism JID - 9607599 RN - 0 (Blood Glucose) RN - 0 (Gastrointestinal Hormones) SB - IM MH - Animals MH - Blood Glucose/*metabolism MH - Diabetes Mellitus/blood/*physiopathology MH - Diabetic Angiopathies/epidemiology/*physiopathology MH - Gastrointestinal Hormones/physiology MH - Humans MH - Hyperglycemia/*physiopathology MH - Postprandial Period/*physiology MH - Risk Factors RF - 73 EDAT- 2000/09/30 11:00 MHDA- 2001/02/28 10:01 CRDT- 2000/09/30 11:00 PHST- 2000/09/30 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/09/30 11:00 [entrez] AID - MDOI-DM-09-2000-26-4-1262-3036-101019-ART2 [pii] PST - ppublish SO - Diabetes Metab. 2000 Sep;26(4):265-72.